TWST Jul 2024 32.500 call
| Previous close | 13.62 |
| Open | 13.62 |
| Bid | 16.70 |
| Ask | 19.40 |
| Strike | 32.50 |
| Expiry date | 2024-07-19 |
| Day's range | 13.62 - 13.62 |
| Contract range | N/A |
| Volume | |
| Open interest | 20 |
ZacksIs DaVita (DVA) Stock Outpacing Its Medical Peers This Year?
Here is how DaVita HealthCare (DVA) and Twist Bioscience (TWST) have performed compared to their sector so far this year.
Business WireTwist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
SOUTH SAN FRANCISCO, Calif., June 06, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the publication of a study detailing the discovery of TB206-001, a first-in-class antibody targeting adenosine A2A receptor (A2AR), a promising molecular target that could enhance cancer immunotherapy. The study titled, "Discovery of a potent, selective, and tumor-suppressing
Business WireTwist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
SOUTH SAN FRANCISCO, Calif., June 04, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that the company has joined the U.S. AI Safety Institute Consortium (AISIC), a group established by the Department of Commerce’s National Institute of Standards and Technology (NIST) to support the development and deployment of trustworthy and safe AI.
